| Product Code: ETC9971423 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Neurovascular Embolization Devices Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Neurovascular Embolization Devices Market - Industry Life Cycle |
3.4 United States (US) Neurovascular Embolization Devices Market - Porter's Five Forces |
3.5 United States (US) Neurovascular Embolization Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Neurovascular Embolization Devices Market Revenues & Volume Share, By Process, 2021 & 2031F |
3.7 United States (US) Neurovascular Embolization Devices Market Revenues & Volume Share, By Therapeutic Applications, 2021 & 2031F |
3.8 United States (US) Neurovascular Embolization Devices Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 United States (US) Neurovascular Embolization Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurovascular diseases in the US |
4.2.2 Technological advancements in neurovascular embolization devices |
4.2.3 Growing demand for minimally invasive procedures in the healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of neurovascular embolization devices |
4.3.2 High cost associated with neurovascular procedures and devices |
4.3.3 Limited awareness among healthcare professionals and patients about neurovascular embolization devices |
5 United States (US) Neurovascular Embolization Devices Market Trends |
6 United States (US) Neurovascular Embolization Devices Market, By Types |
6.1 United States (US) Neurovascular Embolization Devices Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Embolic Coils, 2021- 2031F |
6.1.4 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Bare Detachable Coils, 2021- 2031F |
6.1.5 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Coated Detachable Coils, 2021- 2031F |
6.1.6 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Flow Diversion Devices, 2021- 2031F |
6.1.7 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Liquid Embolic Agents, 2021- 2031F |
6.1.8 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Cerebral Balloon Angioplasty and Stenting Systems, 2021- 2031F |
6.1.9 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Neurovascular Embolization Devices Market, By Process |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Neurothrombectomy, 2021- 2031F |
6.2.3 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Cerebral Angiography, 2021- 2031F |
6.2.4 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Carotid Endarterectomy, 2021- 2031F |
6.2.5 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Stenting, 2021- 2031F |
6.2.6 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Microsurgical Clipping, 2021- 2031F |
6.2.7 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Coiling, 2021- 2031F |
6.3 United States (US) Neurovascular Embolization Devices Market, By Therapeutic Applications |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Brain Aneurysm, 2021- 2031F |
6.3.3 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Stenosis, 2021- 2031F |
6.3.4 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Ischemic Strokes, 2021- 2031F |
6.4 United States (US) Neurovascular Embolization Devices Market, By End-use |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.4.4 United States (US) Neurovascular Embolization Devices Market Revenues & Volume, By Clinics, 2021- 2031F |
7 United States (US) Neurovascular Embolization Devices Market Import-Export Trade Statistics |
7.1 United States (US) Neurovascular Embolization Devices Market Export to Major Countries |
7.2 United States (US) Neurovascular Embolization Devices Market Imports from Major Countries |
8 United States (US) Neurovascular Embolization Devices Market Key Performance Indicators |
8.1 Adoption rate of new neurovascular embolization devices in hospitals and clinics |
8.2 Number of research studies and publications on neurovascular embolization devices |
8.3 Patient satisfaction and outcomes post neurovascular procedures |
9 United States (US) Neurovascular Embolization Devices Market - Opportunity Assessment |
9.1 United States (US) Neurovascular Embolization Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Neurovascular Embolization Devices Market Opportunity Assessment, By Process, 2021 & 2031F |
9.3 United States (US) Neurovascular Embolization Devices Market Opportunity Assessment, By Therapeutic Applications, 2021 & 2031F |
9.4 United States (US) Neurovascular Embolization Devices Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 United States (US) Neurovascular Embolization Devices Market - Competitive Landscape |
10.1 United States (US) Neurovascular Embolization Devices Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Neurovascular Embolization Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here